首页> 美国卫生研究院文献>Springer Open Choice >Synthesis structure and biological activity of novel heterocyclic sulfonyl-carboximidamides
【2h】

Synthesis structure and biological activity of novel heterocyclic sulfonyl-carboximidamides

机译:新型杂环磺酰基-碳亚胺化合物的合成结构和生物学活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AbstractA series of novel heterocyclic sulfonyl-carboximidamides were synthesized in satisfactory yields via condensation of heterocyclic methyl carbimidates with 2-chlorobenzenesulfonamide and 4-chloropyridine-3-sulfonamide. New structures were confirmed by IR and NMR spectra as well as elemental analyses. X-ray crystallography of two derivatives was performed. The single-crystal structures confirmed the presence of a primary amine group in the amidine moiety. All the compounds were screened for their tuberculostatic, antibacterial, and anticancer activities. Preliminary results indicated that target compounds exhibited weak tuberculostatic and antibacterial activities. Seven compounds inhibited the growth of some cancer cell lines, whereas one of the 2-quinoline derivatives displayed favorable activity against all tested cancer cells with GI50 values of 0.92–13 μM.
机译:摘要通过杂环氨基碳酸酯与2-氯苯磺酰胺和4-氯吡啶-3-磺酰胺的缩合反应,以令人满意的收率合成了一系列新型的杂环磺酰基-羧酰亚胺。通过IR和NMR光谱以及元素分析证实了新结构。进行了两种衍生物的X射线晶体学分析。单晶结构证实了moiety部分中存在伯胺基。筛选所有化合物的结核抑菌,抗菌和抗癌活性。初步结果表明,目标化合物的结核抑菌和抗菌活性较弱。七种化合物抑制了某些癌细胞系的生长,而2-喹啉衍生物之一对所有测试的癌细胞表现出良好的活性,GI50值为0.92–13μM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号